Promus - Registry Experience at the Washington Hospital Center, Drug-eluting Stent (DES)
NCT01003795 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2020-10-19
Summary
Single-center registry of patients treated with at least one Promus, everolimus-eluting, Stent, with the primary objective to assess clinical success and safety at 30 days, 6 months and 1 year post-implantation.
Conditions
Sponsors & Collaborators
-
Medstar Health Research Institute
lead OTHER
Principal Investigators
-
Ron Waksman, MD · Medstar Research Institute/Cardiovascular Research Institute
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-10-31
- Primary Completion
- 2012-07-31
- Completion
- 2013-10-31
Countries
- United States
Study Locations
More Related Trials
-
PROMUS PREMIER™ China Post-Approval Study
NCT03273023 ·Status: COMPLETED
-
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
NCT00638794 ·Status: COMPLETED
-
Cortisone or Drug Eluting Stents (DES) as Compared to Bare Metal Stents (BMS) to EliminAte Restenosis
NCT00369356 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
NG PROMUS Stent System for the Treatment of Atherosclerotic Coronary Lesions
NCT01703000 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Effectiveness and Safety of PROMUS Element Stent (IRIS-ELEMENT )
NCT01350791 ·Status: COMPLETED
-
Treatment of Coronary In-Stent Restenosis
NCT01735825 ·Status: COMPLETED ·Phase: NA
-
OPtimal stEnt Deployment stRategy oF Contemporary sTents - Registry to Evaluate Percutaneous Coronary Intervention Using Bioresorbable Scaffolds With Thinner-strut Construction and Guidance by intracOronary Imaging to REduce Scaffold Failure
NCT06919562 ·Status: RECRUITING
-
Clinical Investigation for Everolimus Drug Eluting Stent
NCT06769217 ·Status: COMPLETED ·Phase: PHASE4
-
Vascular Healing of DES at 3 Months
NCT01391871 ·Status: COMPLETED
-
MULTIcentric BElgium/NEtherlands PRO-Kinetic Safety and Efficacy Study
NCT01531725 ·Status: COMPLETED ·Phase: NA
-
Primary FIbrinolysis and Secondary STenting Versus immEdiate Stenting in ST-segment Elevation Myocardial Infarction
NCT04663932 ·Status: UNKNOWN ·Phase: NA
-
First-In-Human Trial of the MiStent Drug-Eluting Stent (DES) in Coronary Artery Disease
NCT01247428 ·Status: COMPLETED ·Phase: PHASE2
-
Optimal Stent Deployment Strategy of Contemporary Stents
NCT05292651 ·Status: RECRUITING ·Phase: NA
-
Non-acute Coronary occlusIon Treated By Everolimus ELuting Stent
NCT00793221 ·Status: COMPLETED ·Phase: PHASE3
-
Artimes Pro Low Profile Dilatation Catheters for Pre-Dilatation in Patients With Symptomatic Ischemic Heart Disease
NCT03301246 ·Status: COMPLETED ·Phase: NA
-
Prospective multicEntric NonranDomized Registry
NCT02496169 ·Status: UNKNOWN ·Phase: NA
-
Drug Eluting Stent (DES) in Primary Angioplasty
NCT00759850 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
PROMUS™ Element™ Everolimus-Eluting Coronary Stent System European Post-Approval Surveillance Study
NCT01148329 ·Status: COMPLETED
-
PROGRESS-AMS 1.0 Clinical Long Term Follow-Up
NCT01610102 ·Status: COMPLETED
-
Complex CAD Treated With PCI With DES Implantation.
NCT06131333 ·Status: COMPLETED
-
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions in Small Vessels
NCT01498692 ·Status: COMPLETED ·Phase: NA
-
An Evaluation of the Commercially Available Medtronic Resolute Integrity Zotarolimus-Eluting Coronary Stent System
NCT01638507 ·Status: COMPLETED ·Phase: NA
-
PROMUS Element Plus US Post-Approval Study
NCT01589978 ·Status: COMPLETED ·Phase: PHASE4
-
Xience V at Wake Forest University Baptist Medical Center (WFUBMC)
NCT00937573 ·Status: COMPLETED
-
A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES)
NCT02698852 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA